Clinical Trials Browser

INDUSTRY × Lymphoma, Non-Hodgkin × Immunotherapy, Adoptive × Clear all

NCT05420493 2024-01-05

Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma

Phase 1 Unknown

Lymphoma, Non-Hodgkin